OP-033 Platelet-to-Lymphocyte Ratio is Associated with No-reflow Phenomenon after Primer Percutaneous Coronary Intervention in Patients with ST-segment Elevation Myocardial Infarction

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-033 Platelet-to-Lymphocyte Ratio is Associated with No-reflow Phenomenon after Primer Percutaneous Coronary Intervention in Patients with ST-segment Elevation Myocardial Infarction

Objectives ST segment elevation myocardial infarction (STEMI) is an important cause of the morbidity and mortality in coronary artery disease. The aim of this study is to investigate the relationship…

read more

OP-032 Association of Red Cell Distribution Width with Blood Pressure Variability in Patients with Never Treated Essential Hypertension

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-032 Association of Red Cell Distribution Width with Blood Pressure Variability in Patients with Never Treated Essential Hypertension

Background Hypertensives in whom the 24-h blood pressure variability (BPV) is low have a lower prevalence and severity of target-organ damage than those in whom BPV is high. The association…

read more

OP-027 Effects of Newly Begun Carvedilol and Nebivolol Treatment on Insulin Resistance and Lipid Profile in Patients with Essential Hypertension

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-027 Effects of Newly Begun Carvedilol and Nebivolol Treatment on Insulin Resistance and Lipid Profile in Patients with Essential Hypertension

Beta blockers are one of the major class of drugs for the treatment of hypertension. However they are not recommended as first-line antihypertensive agents in most of the recent guidelines….

read more

OP-026 Relationship Between Sympathetic Overactivity and Left Ventricular Hypertrophy in Resistant Hypertension

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-026 Relationship Between Sympathetic Overactivity and Left Ventricular Hypertrophy in Resistant Hypertension

Objective Sympathetic overactivity plays an important role on the development of resistant hypertension (RH). However, the effect of sympathetic predominance on left ventricular hypertrophy (LVH) in RH is not very…

read more

OP-031 The Relationship Between Monocyte/HDL Cholesterol Ratio and Aortic Elasticity in Newly-Diagnosed Hypertensive Patients

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-031 The Relationship Between Monocyte/HDL Cholesterol Ratio and Aortic Elasticity in Newly-Diagnosed Hypertensive Patients

Background Impaired aortic elasticity (stiffness) is shown to be associated with cardiovascular morbidity and mortality in essential hypertension. Previous studies showed that activated monocytes and low HDL-cholesterol might have a…

read more

OP-029 Effect of Hypertension on Regional Myocardial Performance and Probnp Levels in Early Imaging Biomarker of Hypertension

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-029 Effect of Hypertension on Regional Myocardial Performance and Probnp Levels in Early Imaging Biomarker of Hypertension

Background We recently have shown in mice using 3rd generation microscopic USG that basal septal hypertrophy (BSH) is an early imaging biomarker of hypertrophy in physiologic and pathologic stress (Circulation…

read more

OP-030 The Association between Plasma Thiols Levels and Left Ventricular Diastolic Dysfunction in Patient with Hypertension

Nov 30, 2016 by in CARDIOLOGY Comments Off on OP-030 The Association between Plasma Thiols Levels and Left Ventricular Diastolic Dysfunction in Patient with Hypertension

Objectives SH are sulfur analogs of alcohols and founds as frees and oxidized form in plasma. The plasma SH source is mainly consisting for the glycine, glutamic acid, cysteine tripeptide…

read more
Get Clinical Tree app for offline access